Developer docs
API playgroundTry for free, no card

Search company profiles

ADMA BioCenters

Full company profile

uuid0022ly2

Namestring
ADMA BioCenters
Legal namestring
ADMA BioCenters Georgia, Inc.
Company typeenum
Private
Founded yearint
2009
Descriptiontext

ADMA BioCenters is a U.S. specialty plasma collection operator that runs a network of FDA-licensed plasmapheresis centers. Founded in 2009 and headquartered in Roswell, Georgia, the company employs between 251 and 500 people and operates ten plasma donation centers across six southeastern states (Georgia, South Carolina, Tennessee, Louisiana, Maryland, and North Carolina). Its core service is collecting human source plasma from compensated individual donors; the underlying technology is automated plasmapheresis, which separates plasma from red blood cells and returns the red cells to the donor with saline replacement, performed with single-use disposable collection equipment. Supporting products include the Donor ADvantage online pre-screening and QR-code check-in platform, designed to shorten returning-donor visit time, and the Buddy Bonus referral program, which pays donors for each successful referral.

The company's revenue model is transaction-based: donors are paid per successful plasma collection, typically via a prepaid debit card, with compensation varying by location, donor status (new versus returning), and promotional programs. Go-to-market is direct-to-consumer, executed through the company website, paid and organic social channels (LinkedIn, Facebook, Instagram), HubSpot-managed call-to-action funnels, and donor referral incentives. Customers are individual adults aged 18–65 residing within roughly 50 miles of a center; the end-beneficiaries of the collected plasma are patients with immune deficiencies, burn and trauma injuries, hemophilia, alpha-1 antitrypsin deficiency, and other conditions treatable with plasma-derived immunoglobulins.

ADMA BioCenters operates as a wholly owned subsidiary of ADMA Biologics, Inc. (NASDAQ: ADMA), a publicly traded biopharmaceutical company that manufactures immune globulin products. The vertical integration provides a guaranteed offtake channel for collected plasma into the parent's manufacturing operations, and BioCenters itself reports no independent funding, no external investors, and no publicly disclosed standalone revenue. The company is certified under FDA 21 CFR Part 820, follows cGMP and CDC protocols, and is positioned as a regulated, regionally concentrated feedstock supplier within its parent's plasma therapeutics supply chain.

Short descriptiontext

ADMA BioCenters operates ten FDA-licensed plasma collection centers across six southeastern U.S. states, collecting source plasma from compensated donors via automated plasmapheresis for its parent company ADMA Biologics (NASDAQ: ADMA) to manufacture immune globulin therapies.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersRoswell, United States
HQ citystring
Roswell
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices10 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
plasma collection services, plasma donation centers, FDA-licensed plasma centers, source plasma supply, plasmapheresis services
Industry1 code
PRIMARYHLAIAHAH
Plasma Collection & Donor Services (Plasmapheresis Centers)
NAICS code1 code
  • Blood and Organ Banks621991
Product category
Plasma Collection Services
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Plasma Collection Services
TypeTransaction Fee
Description

ADMA BioCenters collects human plasma from donors at their FDA-licensed facilities. The plasma collected is used by parent company ADMA Biologics to manufacture immune globulin products for treating immunodeficiency and other conditions. Donors receive compensation for each successful plasma donation.

admabiocenters.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Infrastructure, Marketing or Sales, Technology or R&D, Supply Chain
Pricing details3 tiers
1Per-donation compensation for plasma donors
ModelTransaction based/ take rateBilling cadencePay-as-you-go
Notes

Donors receive payment for each successful plasma donation. Payment via Paysign ADMA BioCenters Visa prepaid card. Contact center for monthly incentives and special collection program compensation rates.

admabiocenters.com
2New donor loyalty bonus program
ModelOtherBilling cadencePay-as-you-go
Notes

New donors can earn additional compensation through loyalty programs. Myrtle Beach location mentions earning up to $825 as a new donor.

admabiocenters.com
3Buddy Bonus referral program
ModelOtherBilling cadencePay-as-you-go
Notes

Referral bonus of $75 per eligible friend referred who completes two donations. Website mentions $100 in some sections, subject to change.

admabiocenters.com
GTM typeB2C
B2C
Offering typeServices
Services
Core offering1 text field

ADMA BioCenters operates a network of FDA-licensed plasma donation centers across the southeastern United States, where it collects human plasma from compensated donors via automated plasmapheresis. The collected plasma is supplied to its parent company, ADMA Biologics, Inc., for use in manufacturing immune globulin therapies and other plasma-derived medications for patients with immune deficiencies and rare diseases.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • Donors can donate up to 2 times within a 7-day period
+1 more record
Product overview1 text field

ADMA BioCenters operates a network of FDA-licensed plasma collection facilities across multiple U.S. states. The core service is plasma donation, where donors contribute plasma used to manufacture life-saving biologics and immunoglobulins for patients with immune deficiencies, burns, hemophilia, and other plasma protein deficiencies. The company offers Donor ADvantage, an online pre-screening questionnaire platform for returning donors, alongside the Buddy Bonus referral program. All facilities follow cGMP standards and FDA compliance regulations.

Scale indicator2 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeOthers
Description

ADMA BioCenters is a wholly owned subsidiary of ADMA Biologics, Inc. The collected plasma is used by ADMA Biologics to manufacture immune globulin products for treating immunodeficiency disorders and other conditions. This vertical integration ensures a guaranteed market for collected plasma.

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers8 records
1BPL Plasma
TypeDirect peer
Description

U.S. plasma collection network affiliated with Bio Products Laboratory (BPL), a fractionator of plasma-derived therapies. Operates a multi-state network of FDA-licensed centers that compete with ADMA BioCenters for the same donor pool and supply an integrated parent manufacturer.

TypeDirect peer
Description

Operates one of the world's largest plasma collection networks (over 350 centers) supplying its own fractionation business. Highly comparable to ADMA BioCenters: vertically integrated plasma collector + fractionator, FDA-licensed U.S. footprint, donor compensation-based model.

TypeRegional player
Description

One of the largest nonprofit blood and plasma collection organizations in the U.S., operating donor centers across multiple states. Comparable in donor-recruitment and FDA-regulated collection operations, though it is a nonprofit and focuses more on whole blood and Source plasma for transfusion use, with a regional rather than nationwide presence.

TypeDirect peer
Description

Plasma-derived therapy manufacturer that operates plasma collection centers in the U.S. (including through the former KedPlasma network) to feed its fractionation operations. Directly comparable as a vertically integrated collector-frationator with a U.S. donor-pay model.

TypeDirect peer
Description

U.S. plasma collection business owned by Takeda, operating more than 200 centers nationwide. Direct competitor for donors in ADMA BioCenters' southeastern markets, and supplies plasma fractionated (in part) for Takeda's immunoglobulin and other plasma-derived products.

TypeDirect peer
Description

Largest plasma collection network globally, operated as a division of CSL Behring. Operates hundreds of FDA-licensed centers across the U.S. and supplies source plasma to CSL Behring's fractionation operations, making it the closest direct peer to ADMA BioCenters in terms of model (donor-pay collection centers feeding a vertically integrated parent).

TypeDirect peer
Description

U.S. subsidiary of Octapharma AG, operating 180+ plasma donation centers across the U.S. Captive supplier of plasma to Octapharma's fractionation operations, with the same donor-pay / vertically-integrated model as ADMA BioCenters.

TypeRegional player
Description

Dutch blood and plasma collector (part of Sanquin Blood Supply) operating plasma collection centers primarily in the Netherlands and Europe. Comparable as a non-U.S. regulated plasma collector feeding a fractionation operation, but does not directly compete with ADMA BioCenters in the U.S. southeastern donor market.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

ADMA BioCenters

Plasma Collection Servicesadmabiocenters.com

ADMA BioCenters operates ten FDA-licensed plasma collection centers across six southeastern U.S. states, collecting source plasma from compensated donors via automated plasmapheresis for its parent company ADMA Biologics (NASDAQ: ADMA) to manufacture immune globulin therapies.

What ADMA BioCenters does

ADMA BioCenters is a U.S. specialty plasma collection operator that runs a network of FDA-licensed plasmapheresis centers. Founded in 2009 and headquartered in Roswell, Georgia, the company employs between 251 and 500 people and operates ten plasma donation centers across six southeastern states (Georgia, South Carolina, Tennessee, Louisiana, Maryland, and North Carolina). Its core service is collecting human source plasma from compensated individual donors; the underlying technology is automated plasmapheresis, which separates plasma from red blood cells and returns the red cells to the donor with saline replacement, performed with single-use disposable collection equipment. Supporting products include the Donor ADvantage online pre-screening and QR-code check-in platform, designed to shorten returning-donor visit time, and the Buddy Bonus referral program, which pays donors for each successful referral.

The company's revenue model is transaction-based: donors are paid per successful plasma collection, typically via a prepaid debit card, with compensation varying by location, donor status (new versus returning), and promotional programs. Go-to-market is direct-to-consumer, executed through the company website, paid and organic social channels (LinkedIn, Facebook, Instagram), HubSpot-managed call-to-action funnels, and donor referral incentives. Customers are individual adults aged 18–65 residing within roughly 50 miles of a center; the end-beneficiaries of the collected plasma are patients with immune deficiencies, burn and trauma injuries, hemophilia, alpha-1 antitrypsin deficiency, and other conditions treatable with plasma-derived immunoglobulins.

ADMA BioCenters operates as a wholly owned subsidiary of ADMA Biologics, Inc. (NASDAQ: ADMA), a publicly traded biopharmaceutical company that manufactures immune globulin products. The vertical integration provides a guaranteed offtake channel for collected plasma into the parent's manufacturing operations, and BioCenters itself reports no independent funding, no external investors, and no publicly disclosed standalone revenue. The company is certified under FDA 21 CFR Part 820, follows cGMP and CDC protocols, and is positioned as a regulated, regionally concentrated feedstock supplier within its parent's plasma therapeutics supply chain.

ADMA BioCenters firmographics

Firmographics
Name
ADMA BioCenters
Legal name
ADMA BioCenters Georgia, Inc.
Website
https://admabiocenters.com
Company type
Private
Founded year
2009
Operating status
Operating
Headcount range
51–100 employees
Short description
ADMA BioCenters operates ten FDA-licensed plasma collection centers across six southeastern U.S. states, collecting source plasma from compensated donors via automated plasmapheresis for its parent company ADMA Biologics (NASDAQ: ADMA) to manufacture immune globulin therapies.
Ownership category
akta.pro rank

ADMA BioCenters industry classification

Industry
Product category
Plasma Collection Services
NAICS
Blood and Organ Banks (621991)
akta.pro industry
PRIMARYHLAIAHAH
Plasma Collection & Donor Services (Plasmapheresis Centers)

Keywords

  • Plasma collection services
  • Plasma donation centers
  • FDA-licensed plasma centers
  • Source plasma supply
  • Plasmapheresis services

Where ADMA BioCenters is headquartered

Location

Headquarters

HQ city
Roswell
HQ country
United States
HQ region
North America

Offices10 records

Markets served

ADMA BioCenters business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Operations, Infrastructure, Marketing or Sales, Technology or R&D, Supply Chain

Revenue model

  1. Plasma Collection Services: ADMA BioCenters collects human plasma from donors at their FDA-licensed facilities. The plasma collected is used by parent company ADMA Biologics to manufacture immune globulin products for treating immunodeficiency and other conditions. Donors receive compensation for each successful plasma donation.

Pricing tiers

ModelBillingPrice
Transaction based/ take ratePay-as-you-goPer-donation compensation for plasma donors
OtherPay-as-you-goNew donor loyalty bonus program
OtherPay-as-you-goBuddy Bonus referral program

Go-to-market motion1 record

Distribution channels1 record

Marketing channels6 records

ADMA BioCenters product offering

Product offering

Core offering

ADMA BioCenters operates a network of FDA-licensed plasma donation centers across the southeastern United States, where it collects human plasma from compensated donors via automated plasmapheresis. The collected plasma is supplied to its parent company, ADMA Biologics, Inc., for use in manufacturing immune globulin therapies and other plasma-derived medications for patients with immune deficiencies and rare diseases.

Product overview

ADMA BioCenters operates a network of FDA-licensed plasma collection facilities across multiple U.S. states. The core service is plasma donation, where donors contribute plasma used to manufacture life-saving biologics and immunoglobulins for patients with immune deficiencies, burns, hemophilia, and other plasma protein deficiencies. The company offers Donor ADvantage, an online pre-screening questionnaire platform for returning donors, alongside the Buddy Bonus referral program. All facilities follow cGMP standards and FDA compliance regulations.

Differentiator

Problem solved

Functional benefit

Quantifiable outcome

  • Donors can donate up to 2 times within a 7-day period
  • +1 more outcomes

Companies that use ADMA BioCenters

Customer profile

Segments2 records

Ideal customer profiles1 record

ADMA BioCenters technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

ADMA BioCenters partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • ADMA BiologicscoreOthersADMA BioCenters is a wholly owned subsidiary of ADMA Biologics, Inc. The collected plasma is used by ADMA Biologics to manufacture immune globulin products for treating immunodeficiency disorders and other conditions. This vertical integration ensures a guaranteed market for collected plasma.

Scale indicators2 records

Recent moves5 records

Expansion highlights4 records

ADMA BioCenters competitors and assessment

Company assessment

Direct peers

  • BPL Plasma: U.S. plasma collection network affiliated with Bio Products Laboratory (BPL), a fractionator of plasma-derived therapies. Operates a multi-state network of FDA-licensed centers that compete with ADMA BioCenters for the same donor pool and supply an integrated parent manufacturer.
  • Grifols: Operates one of the world's largest plasma collection networks (over 350 centers) supplying its own fractionation business. Highly comparable to ADMA BioCenters: vertically integrated plasma collector + fractionator, FDA-licensed U.S. footprint, donor compensation-based model.
  • Kedrion Biopharma: Plasma-derived therapy manufacturer that operates plasma collection centers in the U.S. (including through the former KedPlasma network) to feed its fractionation operations. Directly comparable as a vertically integrated collector-frationator with a U.S. donor-pay model.
  • BioLife Plasma Services: U.S. plasma collection business owned by Takeda, operating more than 200 centers nationwide. Direct competitor for donors in ADMA BioCenters' southeastern markets, and supplies plasma fractionated (in part) for Takeda's immunoglobulin and other plasma-derived products.
  • CSL Plasma: Largest plasma collection network globally, operated as a division of CSL Behring. Operates hundreds of FDA-licensed centers across the U.S. and supplies source plasma to CSL Behring's fractionation operations, making it the closest direct peer to ADMA BioCenters in terms of model (donor-pay collection centers feeding a vertically integrated parent).
  • Octapharma Plasma: U.S. subsidiary of Octapharma AG, operating 180+ plasma donation centers across the U.S. Captive supplier of plasma to Octapharma's fractionation operations, with the same donor-pay / vertically-integrated model as ADMA BioCenters.

Regional players

  • Vitalant: One of the largest nonprofit blood and plasma collection organizations in the U.S., operating donor centers across multiple states. Comparable in donor-recruitment and FDA-regulated collection operations, though it is a nonprofit and focuses more on whole blood and Source plasma for transfusion use, with a regional rather than nationwide presence.
  • Sanquin Plasma: Dutch blood and plasma collector (part of Sanquin Blood Supply) operating plasma collection centers primarily in the Netherlands and Europe. Comparable as a non-U.S. regulated plasma collector feeding a fractionation operation, but does not directly compete with ADMA BioCenters in the U.S. southeastern donor market.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

ADMA BioCenters social profiles

Digital presence

ADMA BioCenters compliance and trust

Trust signal

Compliance1 record

ADMA BioCenters financial estimates

Financial estimate

Revenue estimate

Valuation estimate

ADMA BioCenters leadership team

Management profile

Number of profiles

ADMA BioCenters funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

ADMA BioCenters M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ADMA BioCenters

What does ADMA BioCenters do?

ADMA BioCenters operates a network of FDA-licensed plasma donation centers across the southeastern United States, where it collects human plasma from compensated donors via automated plasmapheresis. The collected plasma is supplied to its parent company, ADMA Biologics, Inc., for use in manufacturing immune globulin therapies and other plasma-derived medications for patients with immune deficiencies and rare diseases.

Is ADMA BioCenters a public or private company?

ADMA BioCenters is a private company. It is classified as corporate owned and is currently operating.

When was ADMA BioCenters founded?

ADMA BioCenters was founded in 2009. It employs 51 to 100 people.

Where is ADMA BioCenters based?

ADMA BioCenters is headquartered in Roswell, United States, in the North America region.

How does ADMA BioCenters make money?

One revenue line is on record: plasma Collection Services.

Who are ADMA BioCenters's main competitors?

Direct peers on record are BPL Plasma, Grifols, Kedrion Biopharma, BioLife Plasma Services, CSL Plasma and Octapharma Plasma. Regional players are Vitalant and Sanquin Plasma.

Does ADMA BioCenters have an API?

No public API is recorded for ADMA BioCenters.

What industry is ADMA BioCenters in?

ADMA BioCenters's product category is Plasma Collection Services. Its primary akta.pro industry code is HLAIAHAH, Plasma Collection & Donor Services (Plasmapheresis Centers). Its NAICS code is 621991.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals